The Importance of Sample Identification in the Biopharmaceutical Industry
The biopharmaceutical industry covers multiple sub-sectors, including drug discovery, clinical trials, cell therapy, and gene sequencing. In these highly advanced research and production processes, accurate specimen identification and full-chain traceability are the cornerstones of data reliability and compliance. A well-designed identification system can significantly reduce the risk of sample mix-ups, loss, and information errors.
Core Elements of Standardized Sample Labeling
Unique Identification Code
Each sample should have a unique ID code. A composite coding rule incorporating project code, sample type, collection date, and serial number is recommended. For example: PROJ001-BLD-20260101-0001. The unique ID ensures sample traceability throughout the entire experimental workflow.
Standardized Label Information
Labels should contain the following basic information: sample ID, sample name, collection date, storage conditions, operator, and remarks. For clinical trial samples, subject number, visit cycle, and other information must also be included to meet GCP requirements.
Label Durability Requirements
Samples in the biopharmaceutical industry typically undergo multiple extreme environments: liquid nitrogen storage (-196 °C), ultra-low temperature freezers (-80 °C), high-temperature autoclaving (121 °C), organic solvent immersion, and long-term thermal cycling. Labels must remain clearly legible and firmly adhered under these conditions without peeling off.
BRD Comprehensive Labeling Solutions
Cryogenic Labels
Suitable for -196 °C liquid nitrogen environments and -80 °C freezer storage, used with cryovials and cryoboxes to ensure specimen identification remains clearly legible under ultra-low temperature conditions. BRD Lab series cryogenic labels have undergone rigorous temperature cycling tests, with no degradation in adhesion.
Chemical-Resistant Labels
Used for pathology slides, tissue embedding cassettes, microscope slides, and similar applications. Resistant to common laboratory solvents such as xylene, ethanol, and formalin. Labels have been tested by organic solvent immersion to ensure text does not dissolve and labels do not peel off.
Autoclave-Resistant Labels
Suitable for laboratory instruments, reagent bottles, and consumable packaging that require high-temperature and high-pressure autoclaving. Labels can be autoclaved together with items (121 °C/20 min) and remain as legible as before.
RFID Smart Labels
Smart labels with integrated RFID chips support batch identification and long-range reading, suitable for automated management of large biobanks. They enable inventory counting and localization of samples inside LN₂ tanks without opening the tank.
Printer and Ribbon Compatibility
BRD offers a complete laboratory label printing solution, including thermal-transfer printers, cryogenic-specific ribbons, and solvent-resistant ribbons, ensuring optimal matching between labels and printing consumables.
Compliance Assurance
BRD label products fully comply with GLP (Good Laboratory Practice), GCP (Good Clinical Practice), and ISO 17025 requirements for specimen identification. All products undergo rigorous performance testing before shipment, and batch quality inspection reports are provided.
For more information on biopharmaceutical industry labeling solutions or to request samples, please contact the BRD technical team.
Related Compliance Standards
Standardization of sample labeling in the biopharmaceutical industry is primarily based on ISO 20387:2018 "Biobanking — General requirements for biobanking" (specimen identification traceability), ISO 17025:2017 (laboratory testing competence and record requirements), and ISO 15189:2022 "Medical laboratories — Requirements for quality and competence"; label adhesion reliability is verified per GB/T 2792-2014.
Recommended Products
For the label materials and application scenarios covered in this article, the following BRD products are available for selection reference (click to view specifications and request a quote):
- MACH4S实验室装备液氮冻存管载玻片生物样本库低温液氮标签打印机 (Request a Quote)
- EOS2/3生物样本库标签打印机医疗实验室低温液氮冻存管锥管离心管 (Request a Quote)
- BBP12贝迪BRADY实验室科研机构医疗生物样本库低温液氮标签打印机 (Request a Quote)
- Lab263-319/45x95mm实验室冻存管载玻片生物样本库标签低温胶BRD博锐迪 (Request a Quote)
FAQ
Q: What are the key points of standardized biopharmaceutical sample labeling?
The core is "unique ID + traceability + environmental resistance": each sample has a unique identification code, label information fully supports end-to-end traceability, and labels withstand the sample's storage environment (low temperature, freeze–thaw, chemical reagents, etc.).
Q: How should label coding rules be designed?
A segmented coding scheme of "project/institution code + sample type + serial number" is recommended, combined with 1D or 2D barcodes to ensure uniqueness and automatic recognition by LIMS.
Q: What are the key considerations when selecting labels for cryogenic samples?
Focus on the face stock's low-temperature embrittlement temperature, the adhesive's low-temperature holding power, and barcode readability under frost/condensation conditions. Freeze–thaw cycle validation at the actual storage temperature is recommended.
Four Major Scenarios of Labeling Needs in the Biopharmaceutical Industry
Labeling needs in the biopharmaceutical industry can be summarized into four major scenarios, each with different priorities for label performance.
| Scenario | Representative Items | Core Requirements |
|---|---|---|
| R&D laboratory | Microcentrifuge tubes, PCR plates, microplates | Low-temperature resistance, chemical resistance, barcode readability |
| Biobank | Cryovials, cryoboxes, LN₂ tanks | -80 °C/-196 °C resistance, freeze–thaw resistance |
| Cold chain logistics | Drugs, vaccines, biological products | Temperature-change resistance, condensation resistance, abrasion resistance |
| Manufacturing | Reagent bottles, raw material drums, equipment | Chemical resistance, batch printing, compliance |
From "Applying a Label" to "Building an Identification System"
Standardized sample labeling is not merely "applying a label" — it is establishing a complete identification system covering numbering rules, label selection, printing standards, and scan verification. It standardizes and digitizes sample identity information, laying the foundation for subsequent data traceability, quality audits, and LIMS integration. For biopharmaceutical companies, the identification system is a critical detail in implementing quality management systems (such as ISO 13485 and GMP).
Benefits of an Identification System
A reliable identification system delivers quantifiable benefits: reduced sample error rates, improved search and inventory efficiency, and smoother audit traceability. As the physical carrier within this system, labels have an extremely low unit cost yet are a fundamental element in safeguarding biopharmaceutical data integrity and compliance — worthy of standardization at the system level.
The Relationship Between Identification Systems and Quality Systems
In the biopharmaceutical industry, the sample identification system is a practical detail of quality systems (GMP, ISO 13485, ISO 15189). Audits frequently check whether "labels are legible and records are traceable," so the value of standardized labeling lies not only in efficiency but also in compliance. Building a complete identification system from numbering to verification provides a solid data foundation for quality systems.